Merck's Zetia Arguments Don't Misuse Privilege, Judge Says
A Virginia federal judge will allow Merck to make certain arguments about how its executives interpreted a patent litigation settlement with rival drugmaker Glenmark over cholesterol drug Zetia despite claims from antitrust plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article